← feed

Is NCT04981561 results overdue?

Yes — results are overdue. Primary completion was 2017-12-21; the FDAAA-801 reporting deadline (2018-12-21) passed 2739 days ago and no results are posted on ClinicalTrials.gov.

Safety and Tolerability of Zelquistinel in Normal Human Volunteers

NCT IDNCT04981561 ↗
SponsorSyndeio Biosciences, Inc (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-12-21 (ACTUAL)
Reporting deadline2018-12-21 (completion + 365d)
Days overdue2739
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 6c23b5c66d7db533… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT04981561. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →